Catalyst Wire Dossier Catalyst Wire Dossier

rDEN2/4delta30 Dengue Vaccine

· National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rDEN2/4delta30 Dengue Vaccine, covering 2013-01-03 to 2013-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine [Phase 1]

See pricing